Who
Robin Wright
Director
Company insider
Files Form 4 as: Director, Barinthus Biotherapeutics.
In numbers
- Trades disclosed
- 22
- Buys
- 3
- Sells
- 0
- Bought
- $374K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 29 Apr 2021
- Last trade
- 9 Sep 2026
- Last filed
- 9 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Sep 2026filed 9 Sep 2026 | Barinthus BiotherapeuticsBiotechnology | SEC FORM 4 Code D | —48,256 | filing |
| 9 Sep 2026filed 9 Sep 2026 | Barinthus Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —20,394 at $0.00 | filing |
| 9 Sep 2026filed 9 Sep 2026 | Barinthus Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —34,328 at $0.00 | filing |
| 9 Sep 2026filed 9 Sep 2026 | Barinthus Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —20,394 at $0.00 | filing |
| 9 Sep 2026filed 9 Sep 2026 | Barinthus Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —34,328 at $0.00 | filing |
| 9 Sep 2026filed 9 Sep 2026 | Barinthus Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —18,604 at $0.00 | filing |
| 9 Sep 2026filed 9 Sep 2026 | Barinthus Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —19,197 at $0.00 | filing |
| 9 Sep 2026filed 9 Sep 2026 | Barinthus Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —19,516 at $0.00 | filing |
| 9 Sep 2026filed 9 Sep 2026 | Barinthus Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —20,174 at $0.00 | filing |
| 9 Sep 2026filed 9 Sep 2026 | Barinthus Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —18,604 at $0.00 | filing |
| 9 Sep 2026filed 9 Sep 2026 | Barinthus Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —19,197 at $0.00 | filing |
| 9 Sep 2026filed 9 Sep 2026 | Barinthus Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —19,516 at $0.00 | filing |
| 9 Sep 2026filed 9 Sep 2026 | Barinthus Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —20,174 at $0.00 | filing |
| 9 Sep 2026filed 9 Sep 2026 | Barinthus BiotherapeuticsBiotechnology | SEC FORM 4 Code D | —48,256 | filing |
| 10 Jun 2025filed 11 Jun 2025 | Barinthus Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,174 at $0.00 | filing |
| 10 May 2024filed 14 May 2024 | Barinthus Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —19,516 at $0.00 | filing |
| 25 May 2023filed 1 Jun 2023 | Barinthus BiotherapeuticsBiotechnology | SEC FORM 4 Bought | $37K13,750 at $2.66 | filing |
| 11 May 2023filed 12 May 2023 | Barinthus Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —19,197 at $0.00 | filing |
| 15 Jun 2022filed 10 Feb 2023 | Barinthus Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —18,604 at $0.00 | filing |
| 22 Dec 2021filed 23 Dec 2021 | Barinthus BiotherapeuticsBiotechnology | SEC FORM 4 Bought | $100K10,000 at $9.97 | filing |
News
No headline names them, or the companies they trade most, lately.